Abstract:Mitochondrial network is constantly in a dynamic and regulated balance of fusion and fission processes, which is known as mitochondrial dynamics. Mitochondria make physical contacts with almost every other membrane in the cell thus impacting cellular functions. Mutations in mitochondrial dynamics genes are known to cause neurogenetic diseases. To better understand the consequences on the cellular phenotype and pathophysiology of neurogenetic diseases associated with defective mitochondrial dynamics, we have compared the fibroblasts phenotypes of (i) patients carrying pathogenic variants in genes involved in mitochondrial dynamics such as DRP1 (also known as DNM1L ), GDAP1 , OPA1 , and MFN2 , and (ii) patients carrying mutated genes that their dysfunction affects mitochondria or induces a mitochondrial phenotype, but that are not directly involved in mitochondrial dynamic network, such as FXN (encoding frataxin, located in the mitochondrial matrix), MED13 (hyperfission phenotype), and CHKB (enlarged mitochondria phenotype). We identified mitochondrial network alterations in all patients’ fibroblasts except for CHKB Q198*/Q198* . Functionally, all fibroblasts showed mitochondrial oxidative stress, without membrane potential abnormalities. The lysosomal area and distribution were abnormal in GDAP1 W67L/W67L , DRP1 K75E/+ , OPA1 F570L/+ , and FXN R165C/GAA fibroblasts. These lysosomal alterations correlated with mitochondria-lysosome membrane contact sites (MCSs) defects in GDAP1 W67L/W67L exclusively. The study of mitochondrial contacts in all samples further revealed a significant decrease in MFN2 R104W/+ fibroblasts. GDAP1 and MFN2 are outer mitochondrial membrane (OMM) proteins and both are related to Charcot-Marie Tooth neuropathy. Here we identified their constitutive interaction as well as MFN2 interaction with LAMP-1. Therefore MFN2 is a new mitochondria-lysosome MCSs protein. Interestingly, GDAP1 W67L/W67L and MFN2 R104W/+ fibroblasts carry pathogenic changes that occur in their catalytic domains thus suggesting a functional role of GDAP1 and MFN2 in mitochondria–lysosome MCSs. Finally, we observed starvation-induced autophagy alterations in DRP1 K75E/+ , GDAP1 W67L/W67L , OPA1 F570L/+ , MFN2 R104W/+ , and CHKB Q198*/Q198* fibroblasts. These genes are related to mitochondrial membrane structure or lipid composition, which would associate the OMM with starvation-induced autophagy. In conclusion, the study of mitochondrial dynamics and mitochondria-lysosome axis in a group of patients with different neurogenetic diseases has deciphered common and unique cellular phenotypes of degrading and non-degrading pathways that shed light on pathophysiological events, new biomarkers and pharmacological targets for these disorders.

Novel Insight into the Potential Pathogenicity of Mitochondrial Dysfunction Resulting from PLP1 Duplication Mutations in Patients with Pelizaeus–Merzbacher Disease

Identification and Functional Study of Novel PLP1 Mutations in Chinese Patients with Pelizaeus–Merzbacher Disease

The natural history of Pelizaeus–Merzbacher disease caused by PLP1 duplication: A multiyear case series

Induced Pluripotent Stem Cells with a Mitochondrial DNA Deletion.

STEM CELLS ® EMBRYONIC STEM CELLS / INDUCED PLURIPOTENT STEM CELLS Induced Pluripotent Stem Cells with a Pathological Mitochondrial DNA Deletion

Proteolipid Protein 1 Gene Mutation in Nine Patients with Pelizaeus-Merzbacher Disease

Pelizaeus–Merzbacher disease: on the cusp of myelin medicine

Molecular Genetic Analysis of the PLP1 Gene in 38 Families with PLP1-related disorders: Identification and Functional Characterization of 11 Novel PLP1 Mutations

[Clinical and Genetic Analysis of a Family with Pelizaeus-Merzbacher Disease].

Genotype–phenotype Correlation and Natural History Analyses in a Chinese Cohort with Pelizaeus–merzbacher Disease

Study on proteolipid protein 1 gene mutation in a Chinese pedigree with Pelizaeus-Merzbacher disease

Pelizaeus-Merzbacher Disease: Molecular Diagnosis and Therapy

Gene Mutations and Prenatal Diagnosis in Six Pedigrees with Pelizaeus-Merzbacher Disease

Biallelic PTPMT1 variants disrupt cardiolipin metabolism and lead to a neurodevelopmental syndrome

Generation of Pelizaeus-Merzbacher disease (PMD) mutant (PLP1-C33Y) in induced pluripotent stem cell (iPSC) by CRISPR/Cas9 genome editing

Generation of the Human Induced Pluripotent Stem Cell Line (Zjui005-A) from a Patient with Pelizaeus-Merzbacher Disease (PMD) Carrying a Novel Hemizygous Mutation in PLP1 Gene

Mitochondrial Dynamics and Mitochondria-Lysosome Contacts in Neurogenetic Diseases

HPDL deficiency causes a neuromuscular disease by impairing the mitochondrial respiration

PSMF1 variants cause a phenotypic spectrum from early-onset Parkinson's disease to perinatal lethality by disrupting mitochondrial pathways

MRI Findings of Pelizaeus-Merzbacher Disease Correlated with Phenotypes and Genetic Mutation

Combined Genetic and Imaging Diagnosis for Two Large Chinese Families Affected with Pelizaeus-Merzbacher Disease